DNA Damage Response

Advertisement

cGxPJobs Banner

Senhwa Completes CX-5461 Phase 1b Trial Enrollment

TAIPEI, Taiwan — August 25, 2026 Senhwa Biosciences announced that it has completed patient enrollment in its Phase 1b...

By cGxPwire Editor
August 26, 2026

Read More

GSK Seeks EMA Approval for Bexsero Booster Vaccine Update

LONDON, United Kingdom, July 20, 2026 GSK plc has announced that the European Medicines Agency (EMA) has accepted its...

By cGxPwire Editor
July 21, 2026

Read More

BioLineRx to Present GLIX1 Ovarian Cancer Data at ESMO 2026

TEL AVIV, Israel & OSLO, Norway, July 20, 2026 BioLineRx Ltd. and Hemispherian AS have announced that new preclinical...

By cGxPwire Editor
July 21, 2026

Read More

BioLineRx and Hemispherian Showcase GLIX1 Cancer Data at ASCO 2026

Tel Aviv, Israel and Oslo, Norway – May 22, 2026 BioLineRx Ltd. and Hemispherian AS announced new preclinical and...

By cGxPwire Editor
May 23, 2026

Read More

Advertisement

cGxPJobs

Directory